Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash
ECHEMI chemical news

Market Flash

Johnson & Johnson's Tau Monoclonal Antibody Receives FDA Fast Track Designation on January 8

Johnson & Johnson's Tau Monoclonal Antibody Receives FDA Fast Track Designation on January 8

2025-01-10

The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson fast track designation for its developing Tau monoclonal antibody Posdinemab for the treatment of early Alzheimer's disease (AD) patients. This decision was announced on January 8.

Jia Tongchun(North New Building Materials) Sells 3.5 Million Shares, Cashing Out Over 100 Million

Jia Tongchun(North New Building Materials) Sells 3.5 Million Shares, Cashing Out Over 100 Million

2025-01-10

North New Building Materials announced on January 9, 2025, that company shareholder and Vice Chairman Jia Tongchun and his concerted parties have completed their share reduction plan, totaling 3.5 million shares. Mr. Jia personally reduced 3.3433 million

Elementis Price Increase Effective January 15, 2025

Elementis Price Increase Effective January 15, 2025

2025-01-10

Elementis recently issued an official announcement stating that it will adjust the prices of its Performance Specialties products effective January 15, 2025.

Germany's Bankruptcies Expected to Increase by 25% to 30% in 2025, Hitting Record Highs

Germany's Bankruptcies Expected to Increase by 25% to 30% in 2025, Hitting Record Highs

2025-01-10

According to analysis by restructuring consultancy Falkensteg, Germany is expected to face a wave of severe bankruptcies in 2025, with the number of business closures likely to increase by 25% to 30% compared to 2024, reaching the highest level since the

UPM Raflatac partners with Highlands to expand its presence in the UK notepad market

UPM Raflatac partners with Highlands to expand its presence in the UK notepad market

2025-01-10

UPM Raflatac has announced a new partnership with Highlands to boost sales of UPM Raflatac’s office products in the UK. Highlands will support the growth objectives of the notepad business under UPM Raflatac’s inFO Notes and UPM Notes brands.

Perstorp Opens Plant in Amsterdam to Enter Synthetic Ester Business

Perstorp Opens Plant in Amsterdam to Enter Synthetic Ester Business

2025-01-10

Global specialty chemicals innovator Perstorp, a wholly owned subsidiary of Malaysia’s Petronas Chemical Group Berhad (PCG), will serve the growing specialty fluids market from its new plant in Amsterdam.

Viridis Chemical Relocates Renewable Ethyl Acetate Plant to Peoria

Viridis Chemical Relocates Renewable Ethyl Acetate Plant to Peoria

2025-01-10

Viridis Chemical has announced the relocation of its renewable chemicals plant from Columbus, Nebraska to Peoria, Illinois.

Borosil Renewables Announces 50% Expansion of Solar Glass Production Capacity

Borosil Renewables Announces 50% Expansion of Solar Glass Production Capacity

2025-01-09

Borosil Renewables Limited, India’s largest and oldest solar glass manufacturer, has announced a 50% expansion of its solar glass production capacity, re-emphasizing its commitment to Atmanirbhar Bharat.

Coffee Prices Soar 70%, Hitting 50-Year High

Coffee Prices Soar 70%, Hitting 50-Year High

2025-01-09

Analysts point out that the record rise in coffee prices shows no signs of slowing down. Some experts warn that as one of the most traded commodities globally, it may take years for coffee prices to recover. The price of coffee for March delivery reached

Singapore Food Safety Law: Three-Year Ban for Violations

Singapore Food Safety Law: Three-Year Ban for Violations

2025-01-09

On Wednesday, January 8, the Singapore Parliament officially passed a bill aimed at updating the food safety system. This bill stipulates that operators whose licenses are revoked due to food safety violations will face a ban on license eligibility for up

Puli Pharmaceuticals Faces Delisting Warning for $1 Billion Fraud

Puli Pharmaceuticals Faces Delisting Warning for $1 Billion Fraud

2025-01-09

Puli Pharmaceuticals announced on January 5, 2025, that it is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws. The company received an "Administrative Penalty Notice" from th

Isatuximab Approved for Sale in China as a Treatment for Multiple Myeloma

Isatuximab Approved for Sale in China as a Treatment for Multiple Myeloma

2025-01-09

Sanofi announced on January 9 that its CD38 monoclonal antibody isatuximab injection has been approved for sale in China. This medication will be used in combination with pomalidomide and dexamethasone to treat adult patients with multiple myeloma (MM) wh

Significant Financial Support for Equipment Upgrade Loans in 2024

Significant Financial Support for Equipment Upgrade Loans in 2024

2025-01-09

The Ministry of Finance recently issued a notice aimed at further strengthening support for equipment upgrades and technological transformations. According to this notice, eligible equipment upgrade loans that are issued after March 7, 2024,

Pakistan to Ban Ozone-Depleting Materials Starting 2025

Pakistan to Ban Ozone-Depleting Materials Starting 2025

2025-01-09

In Pakistan, Finance Minister Muhammad Aurangzeb presided over a meeting of the Cabinet Economic Coordination Committee (ECC), which officially approved an immediate ban on the use of ozone-depleting insulation and foaming materials. These materials are p

Malaysia Imposes Anti-Dumping Duties on Chinese PET Imports, with a Maximum Rate of 37.4%

Malaysia Imposes Anti-Dumping Duties on Chinese PET Imports, with a Maximum Rate of 37.4%

2025-01-09

The Malaysian government has imposed provisional anti-dumping duties on polyethylene terephthalate (PET) imports from China and Indonesia, ranging from 6.3% to 37.4%.

Hengrui Medicine Plans to Go Public in Hong Kong, Innovative Drug Revenue Soars!

Hengrui Medicine Plans to Go Public in Hong Kong, Innovative Drug Revenue Soars!

2025-01-08

On January 6, 2025, the Hong Kong Stock Exchange (HKEX) announced on its official website that Hengrui Medicine has submitted a listing application to the HKEX. The joint sponsors for this listing application are Morgan Stanley, Citi, and Huatai Internati

China Approves First Male HPV Vaccine, Suitable for Ages 9-26!

China Approves First Male HPV Vaccine, Suitable for Ages 9-26!

2025-01-08

The National Medical Products Administration has approved several new indications for the Gardasil vaccine (quadrivalent human papillomavirus vaccine, yeast-derived) by Merck & Co., suitable for males aged 9 to 26. This approval makes Gardasil the first a

India Imposes Duties on Acrylic Sheets from China! Rate is $0.18/kg

India Imposes Duties on Acrylic Sheets from China! Rate is $0.18/kg

2025-01-08

On December 26, 2024, the Ministry of Commerce of India announced in an announcement the affirmative final ruling on anti-dumping for acrylic sheets (Acrylic Solid Surfaces) originating from or imported from China. The announcement recommends imposing a f

Hisense Invents Eco-friendly Coating, Reducing Costs and Extending Lifespan!

Hisense Invents Eco-friendly Coating, Reducing Costs and Extending Lifespan!

2025-01-08

According to information released by the National Intellectual Property Administration on January 7, 2025, Hisense (Guangdong) Kitchen and Bathroom System Co., Ltd. submitted a patent application titled "An Eco-friendly Coating and Its Spraying Method" in

The Body Shop Ends Operations in Brazil

The Body Shop Ends Operations in Brazil

2025-01-08

The British cosmetics brand announced the closure of all its operations in Brazil in an Instagram post published on January 2, 2025.

  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.